TESSA L. HOLYOAKE: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells

Kuntz, Elodie M, Baquero, Pablo, Michie, Alison M, Dunn, Karen, Tardito, Saverio, Holyoake, Tessa L, Helgason, G Vignir, Gottlieb, Eyal

Journal:

Nature Medicine

Year:

2017

Language:

english

File:

PDF, 1.20 MB

english, 2017

2

Role of autophagy in cancer prevention, development and therapy

Helgason, G. Vignir, Holyoake, Tessa L., Ryan, Kevin M.

Journal:

Essays in Biochemistry

Year:

2013

Language:

english

File:

PDF, 1.14 MB

english, 2013

3

Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

Mark W. Drummond, Tessa L. Holyoake

Journal:

Year:

2003

Language:

english

File:

PDF, 80 KB

english, 2003

4

Granulocyte—colony-stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase myelogenous leukemia

Heather G. Jørgensen, Mhairi Copland, Tessa L. Holyoake

Journal:

Year:

2005

Language:

english

File:

PDF, 58 KB

english, 2005

5

A comparison of normal and leukemic stem cell biology in Chronic Myeloid Leukemia

Heather G. JØrgensen, Tessa L. Holyoake

Journal:

Hematological Oncology

Year:

2001

Language:

english

File:

PDF, 250 KB

english, 2001

6

Therapeutic targets in chronic myeloid leukaemia

Nicholas B. Heaney, Tessa L. Holyoake

Journal:

Hematological Oncology

Year:

2007

Language:

english

File:

PDF, 162 KB

english, 2007

7

Optimising chronic myeloid leukaemia therapy in the face of resistance to tyrosine kinase inhibitors – A synthesis of clinical and laboratory data

David A. Irvine, Nicholas B. Heaney, Tessa L. Holyoake

Journal:

Year:

2010

Language:

english

File:

PDF, 270 KB

english, 2010

8

Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory

Dr Tessa L. Holyoake

Journal:

British Journal of Haematology

Year:

2001

Language:

english

File:

PDF, 248 KB

english, 2001

9

In vivo expansion of the endogenous B-cell compartment stimulated by radiation and serial bone marrow transplantation induces B-cell leukaemia in mice

Tessa L. Holyoake, Mary G. Freshney, Kay Samuel, John Ansell, Gwyneth E. Watson, Eric G. Wright, Gerard J. Graham, Ian B. Pragnell

Journal:

British Journal of Haematology

Year:

2001

Language:

english

File:

PDF, 401 KB

english, 2001

10

BCR-ABL FISH monitoring of CML: a survey of current UK practice

Mark W. Drummond, Lynn M. Hendry, Edward Maher, Tessa L. Holyoake

Journal:

British Journal of Haematology

Year:

2002

Language:

english

File:

PDF, 527 KB

english, 2002

11

Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic remission

Mark W. Drummond, David Marin, Richard E. Clark, Jenny L. Byrne, Tessa L. Holyoake, Anne Lennard, on behalf of the United Kingdom Chronic Myeloid Leukaemia (UK CML) Working Party

Journal:

British Journal of Haematology

Year:

2003

Language:

english

File:

PDF, 77 KB

english, 2003

12

Targeted therapy in haematological malignancies

Ashley Hamilton, Paolo Gallipoli, Emma Nicholson, Tessa L Holyoake

Journal:

The Journal of Pathology

Year:

2010

Language:

english

File:

PDF, 2.09 MB

english, 2010

13

Targeting Chronic Myeloid Leukemia Stem Cells

G. Vignir Helgason, Graham A. R. Young, Tessa L. Holyoake

Journal:

Current Hematologic Malignancy Reports

Year:

2010

Language:

english

File:

PDF, 221 KB

english, 2010

14

In Search of CML Stem Cells’ Deadly Weakness

Francesca Pellicano, Amy Sinclair, Tessa L. Holyoake

Journal:

Current Hematologic Malignancy Reports

Year:

2011

Language:

english

File:

PDF, 145 KB

english, 2011

15

The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemia

Stephen D. Griffiths, John Burthem, Richard D. Unwin, Tessa L. Holyoake, Junia V. Melo, Guy S. Lucas, Anthony D. Whetton

Journal:

Molecular Biotechnology

Year:

2007

Language:

english

File:

PDF, 239 KB

english, 2007

16

Poor performance of galactomannan and mannan sandwich enzyme-linked immunosorbent assays in the diagnosis of invasive fungal infection

Elaine K. Allan, Niove E. Jordanides, Lorna A. McLintock, Mhairi Copland, Maureen Devaney, Karen Stewart, Anne N. Parker, Peter R.E. Johnson, Tessa L. Holyoake, Brian L. Jones

Journal:

British Journal of Haematology

Year:

2005

Language:

english

File:

PDF, 53 KB

english, 2005

17

GATA1 mutational analysis in chronic myeloid leukaemia

Christina Halsey, Chris Fisher, Gordon Strathdee, Brenda Gibson, Tessa Holyoake, Paresh Vyas, Gerry Graham

Journal:

British Journal of Haematology

Year:

2007

Language:

english

File:

PDF, 117 KB

english, 2007

18

Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML)

Jim A. Murray, Farhat L. Khanim, Rachel E. Hayden, Charlie F. Craddock, Tessa L. Holyoake, Nick Jackson, Matthew Lumley, Chris M. Bunce, Mark T. Drayson

Journal:

British Journal of Haematology

Year:

2010

Language:

english

File:

PDF, 78 KB

english, 2010

19

Restricted access to second generation tyrosine kinase inhibitors in the UK could result in suboptimal treatment for almost half of chronic myeloid leukaemia patients: results from a West of Scotland and Lothian population study

Paolo Gallipoli, Pat Shepherd, David Irvine, Mark Drummond, Tessa Holyoake

Journal:

British Journal of Haematology

Year:

2011

Language:

english

File:

PDF, 110 KB

english, 2011

20

A Multinational Study of Health State Preference Values Associated with Chronic Myelogenous Leukemia

Shelagh M. Szabo, Adrian R. Levy, Catherine Davis, Tessa L. Holyoake, Jorge Cortes

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 100 KB

english, 2010

21

Telomere Length Dynamics in Normal Individuals and in Patients with Hematopoietic Stem Cell-Associated Disorders

TIM H. BRÜMMENDORF, NATHALIE RUFER, TESSA L. HOLYOAKE, JAREK MACIEJEWSKI, MICHAEL J. BARNETT, CONNIE J. EAVES, ALLEN C. EAVES, NEAL YOUNG, PETER M. LANSDORP

Journal:

Annals of the New York Academy of Sciences

Year:

2001

Language:

english

File:

PDF, 2.18 MB

english, 2001

22

Concise Review: Telomere Biology in Normal and Leukemic Hematopoietic Stem Cells

Mark W. Drummond, Stefan Balabanov, Tessa L. Holyoake, Tim H. Brummendorf

Journal:

Year:

2007

Language:

english

File:

PDF, 318 KB

english, 2007

23

Transcriptional Analysis of Quiescent and Proliferating CD34+ Human Hemopoietic Cells from Normal and Chronic Myeloid Leukemia Sources

Susan M. Graham, J. Keith Vass, Tessa L. Holyoake, Gerard J. Graham

Journal:

Year:

2007

Language:

english

File:

PDF, 1.05 MB

english, 2007

24

Investigation into omacetaxine solution stability for in vitro study

Lamin Marenah, Elaine K. Allan, Joanne C. Mountford, Tessa L. Holyoake, Heather G. Jørgensen, Moira A. Elliott

Journal:

Biomedical Chromatography

Year:

2012

Language:

english

File:

PDF, 139 KB

english, 2012

25

Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate

Bin Zhang, Adam C. Strauss, Su Chu, Min Li, Yinwei Ho, Keh-Dong Shiang, David S. Snyder, Claudia S. Huettner, Leonard Shultz, Tessa Holyoake, Ravi Bhatia

Journal:

Year:

2010

Language:

english

File:

PDF, 1021 KB

english, 2010

26

Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib

Ling Li, Lisheng Wang, Liang Li, Zhiqiang Wang, Yinwei Ho, Tinisha McDonald, Tessa L. Holyoake, WenYong Chen, Ravi Bhatia

Journal:

Year:

2012

Language:

english

File:

PDF, 2.44 MB

english, 2012

27

Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia

Bin Zhang, Yin Wei Ho, Qin Huang, Takahiro Maeda, Allen Lin, Sung-uk Lee, Alan Hair, Tessa L. Holyoake, Claudia Huettner, Ravi Bhatia

Journal:

Year:

2012

Language:

english

File:

PDF, 1.51 MB

english, 2012

28

Enhanced CML stem cell elimination in vitro by bryostatin priming with imatinib mesylate

Heather G. Jørgensen, Elaine K. Allan, Joanne C. Mountford, Linda Richmond, Simon Harrison, Moira A. Elliott, Tessa L. Holyoake

Journal:

Experimental Hematology

Year:

2005

Language:

english

File:

PDF, 181 KB

english, 2005

29

Optimization of methods for the detection of BCR-ABL activity in Philadelphia-positive cells

Ashley Hamilton, Fatma Alhashimi, Svetlana Myssina, Heather G. Jorgensen, Tessa L. Holyoake

Journal:

Experimental Hematology

Year:

2009

Language:

english

File:

PDF, 262 KB

english, 2009

30

Inhibition of MDR1 does not sensitize primitive chronic myeloid leukemia CD34+ cells to imatinib

Sophia Hatziieremia, Niove E. Jordanides, Tessa L. Holyoake, Joanne C. Mountford, Heather G. Jørgensen

Journal:

Experimental Hematology

Year:

2009

Language:

english

File:

PDF, 352 KB

english, 2009

31

Uptake of synthetic Low Density Lipoprotein by leukemic stem cells — a potential stem cell targeted drug delivery strategy

Peixun Zhou, Sophia Hatziieremia, Moira A. Elliott, Linda Scobie, Claire Crossan, Alison M. Michie, Tessa L. Holyoake, Gavin W. Halbert, Heather G. Jørgensen

Journal:

Journal of Controlled Release

Year:

2010

Language:

english

File:

PDF, 894 KB

english, 2010

32

Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow

Tessa L Holyoake, Franck E Nicolini, Connie J Eaves

Journal:

Experimental Hematology

Year:

1999

Language:

english

File:

PDF, 226 KB

english, 1999

33

BCR-ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia

Swagata Roy, Heather G. Jørgensen, Poornima Roy, Mohamed Abed El Baky, Junia V. Melo, Gordon Strathdee, Tessa L. Holyoake, Chris Bartholomew

Journal:

British Journal of Haematology

Year:

2012

Language:

english

File:

PDF, 406 KB

english, 2012

34

Effects of the novel aurora kinase/JAK inhibitor, AT9283 and imatinib on Philadelphia positive cells in vitro

Mohsin Shah, Paolo Gallipoli, John Lyons, Tessa Holyoake, Heather Jørgensen

Journal:

Blood Cells, Molecules, and Diseases

Year:

2012

Language:

english

File:

PDF, 427 KB

english, 2012

35

Not so NICE for CML

John Goldman, Jane Apperley, Richard Clark, Tony Green, Tessa Holyoake, Stephen O'Brien, Pat Shepherd

Journal:

Year:

2002

Language:

english

File:

PDF, 46 KB

english, 2002

36

Evolution of bone marrow transplantation – the original immunotherapy

John D.M. Campbell, Gordon Cook, Tessa L. Holyoake

Journal:

Trends in Immunology

Year:

2001

Language:

english

File:

PDF, 82 KB

english, 2001

37

Quantitative proteomics analysis of BMS-214662 effects on CD34 positive cells from chronic myeloid leukaemia patients

Balabanov, Stefan, Evans, Caroline A., Abraham, Sheela A., Pellicano, Francesca, Copland, Mhairi, Walker, Michael J., Whetton, Anthony D., Holyoake, Tessa L.

Journal:

Year:

2013

Language:

english

File:

PDF, 1.10 MB

english, 2013

38

The Chronic Myeloid Leukemia Stem Cell

Nicholson, Emma, Holyoake, Tessa

Journal:

Clinical Lymphoma & Myeloma

Year:

2009

File:

PDF, 1.80 MB

2009

39

Proceedings of the Third Global Workshop on Chronic Myeloid Leukemia

Giuseppe Saglio, Hagop Kantarjian, Tessa Holyoake, Aarati Ranganathan, Jorge E. Cortés

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2010

Language:

english

File:

PDF, 141 KB

english, 2010

40

Hurdles Toward a Cure for CML: The CML Stem Cell

Gallipoli, Paolo, Abraham, Sheela A., Holyoake, Tessa L.

Journal:

Hematology/Oncology Clinics of North America

Year:

2011

Language:

english

File:

PDF, 313 KB

english, 2011

41

Mechanisms and novel approaches in overriding tyrosine kinase inhibitor resistance in chronic myeloid leukemia

Karvela, Maria, Helgason, G Vignir, Holyoake, Tessa L

Journal:

Expert Review of Anticancer Therapy

Year:

2012

Language:

english

File:

PDF, 1009 KB

english, 2012

42

Autocrine Production and Action of IL-3 and Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia

Xiaoyan Jiang, Angel Lopez, Tessa Holyoake, Allen Eaves and Connie Eaves

Journal:

Proceedings of the National Academy of Sciences

Year:

1999

Language:

english

File:

PDF, 1.26 MB

english, 1999

43

Telomere Shortening Correlates with Prognostic Score at Diagnosis and Proceeds Rapidly during Progression of Chronic Myeloid Leukemia

Drummond, Mark W, Lennard, Anne, Brûmmendorf, Tim H, Holyoake, Tessa L

Journal:

Leukemia and Lymphoma

Year:

2004

Language:

english

File:

PDF, 333 KB

english, 2004

44

The Number of CD34 + Cells Mobilized into the Peripheral Blood Can Predict the Quality of Subsequent Collections

Alcorn, Michael J., Farrell, Elizabeth, Barr, John, Pearson, Charles, Green, Rachel, Holyoake, Tessa

Journal:

Journal of Hematotherapy & Stem Cell Research

Year:

2000

Language:

english

File:

PDF, 125 KB

english, 2000

45

Concise Review: Cancer Cells Escape from Oncogene Addiction: Understanding the Mechanisms Behind Treatment Failure for More Effective Targeting

Pellicano, Francesca, Mukherjee, Leena, Holyoake, Tessa L.

Journal:

Year:

2014

Language:

english

File:

PDF, 191 KB

english, 2014

46

Do we need more drugs for chronic myeloid leukemia?

Holyoake, Tessa L., Helgason, G. Vignir

Journal:

Immunological Reviews

Year:

2015

Language:

english

File:

PDF, 432 KB

english, 2015

47

Antibody-based detection of protein phosphorylation status to track the efficacy of novel therapies using nanogram protein quantities from stem cells and cell lines

Aspinall-O'Dea, Mark, Pierce, Andrew, Pellicano, Francesca, Williamson, Andrew J, Scott, Mary T, Walker, Michael J, Holyoake, Tessa L, Whetton, Anthony D

Journal:

Nature Protocols

Year:

2014

Language:

english

File:

PDF, 1.13 MB

english, 2014

48

DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia

Valent, Peter, Sadovnik, Irina, Ráčil, Zdeněk, Herrmann, Harald, Blatt, Katharina, Cerny-Reiterer, Sabine, Eisenwort, Gregor, Lion, Thomas, Holyoake, Tessa, Mayer, Jiří

Journal:

European Journal of Clinical Investigation

Year:

2014

Language:

english

File:

PDF, 362 KB

english, 2014

49

Eradication of Chronic Myeloid Leukemia Stem Cells: A Novel Mathematical Model Predicts No Therapeutic Benefit of Adding G-CSF to Imatinib

Foo, Jasmine, Drummond, Mark W., Clarkson, Bayard, Holyoake, Tessa, Michor, Franziska, Fraser, Christophe

Journal:

PLoS Computational Biology

Year:

2009

Language:

english

File:

PDF, 538 KB

english, 2009

50

Acute Cardiotoxicity After Daunorubicin in Acute Myeloid Leukaemia

Holyoake, Tessa L., Hillan, Kenneth J., Lucie, Norman P.

Journal:

Leukemia and Lymphoma

Year:

1991

Language:

english

File:

PDF, 416 KB

english, 1991